Back to top
more

Penumbra (PEN)

(Delayed Data from NYSE)

$233.30 USD

233.30
525,994

+4.43 (1.94%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $233.26 -0.04 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Can Penumbra (PEN) Spring a Surprise this Earnings Season?

Penumbra Inc. (PEN) is slated to release fourth-quarter 2016 results on Feb 28, after market close.

    Can The Uptrend Continue for Penumbra (PEN)?

    Investors certainly have to be happy with Penumbra Inc (PEN) and its short term performance

      Becton, Dickinson Commercially Launches Precise WTA Kits

      Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has made its Precise whole transcriptome analysis kits commercial available.

        Baxter (BAX): Sluggish Macro Environment Mars Prospects

        On Jan 17, we issued an updated research report on Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company and leading provider of renal and hospital products.

          Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and Sunrun

          Zacks.com featured highlights: Ollie's Bargain Outlet Holdings, Premier, Penumbra, DigitalGlobe and Sunrun

            Medidata Solutions Clinical Cloud Gets Picked by Celgene

            Medidata Solutions Inc. (MDSO) recently announced that Celgene Corporation adopted Medidata Clinical Cloud.

              Pacific Biosciences (PACB) to Sell 10 PacBio Sequel Systems

              Pacific Biosciences of California, Inc. (PACB), announced that it will sell 10 PacBio Sequel Systems to Novogene Bioinformatics Technology Company, Ltd.

                Akers Biosciences (AKER) Closes Offering of 1.7M Shares

                Akers Biosciences, Inc. (AKER) recently announced the closing of a public offering of 1.7 million common shares.

                  Intuitive Surgical (ISRG) Expects Strong Revenues in Q4

                  Intuitive Surgical, Inc. (ISRG) announced that it expects fourth-quarter 2016 revenues of approximately $757 million.

                    Henry Schein Hurt by Higher Costs, Lacks Growth Drivers

                    On Jan 10, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).

                      Illumina and Bio-Rad Unveil Single-Cell Sequencing Solution

                      Illumina, Inc. (ILMN) recently teamed up with Bio-Rad Laboratories (BIO) to launch the Illumina Bio-Rad Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference.

                        Fluidigm: Q4 Preliminary Results Fail to Cheer Investors

                        The market is not really happy with South San Francisco, CA-based Fluidigm Corporation's (FLDM) preliminary results for the fourth quarter and full-year 2016.

                          Ecolab (ECL) Acquires Abednego Environmental, Shares Gain

                          In a bid to strengthen its water solution line of offerings, St. Paul, MN-based Ecolab Inc. (ECL) announced the acquisition of Abednego Environmental Services.

                            NuVasive at 52-Week High on Preliminary Results, MHLW Nod

                            Share price of San Diego, CA-based NuVasive, Inc. (NUVA) scaled a new 52-week high of $71.03 on Jan 11, finally closing a tad lower at $70.7.

                              Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance

                              Luminex Corporation (LMNX) announced that it expects revenues in the fourth quarter of 2016 to be approximately $72 million and approximately $271 million for full-year 2016.

                                DexCom Looking Forward to Strong Revenues in Q4 and 2016

                                DexCom, Inc. (DXCM), a renowned medical device company, reported that it expects preliminary, unaudited revenue of approximately $168 million for the fourth quarter ended Dec 31, 2016.

                                  K2M Group Holdings (KTWO) in Focus: Stock Up 6.3%

                                  K2M Group Holdings, Inc. (KTWO) saw its shares rise above 6% in the last trading session.

                                    Integra LifeSciences at 52-Week High on Deals, View Update

                                    Shares of Integra LifeSciences Holdings Corporation (IART), a global leader in medical technology, scaled a new 52-week high of $45.50 on Jan 10, closing a tad lower at $44.90.

                                      Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS

                                      Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.

                                        PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics

                                        PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.

                                          Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels

                                          Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.

                                            Air Methods (AIRM): Winter Hits December Passenger Count

                                            Air Methods Corporation (AIRM), reported tepid preliminary patient transport and tourism passenger data for the month of Dec 2016.

                                              AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View

                                              AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.

                                                Cerner Extends HNM Partnership with University of Missouri

                                                Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.

                                                  Alere Forensic Toxicology Division Gets ABFT Accreditation

                                                  Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.